Company intelligence / Profile preview

Marion Laboratories

Kansas City, Missouri, United States
Ownership
Private
Employees
~3400
Development stage
Other
01

Overview

Marion Laboratories was known for marketing drugs discovered by other companies rather than conducting extensive in-house research. Their most successful product was Cardizem, a calcium channel blocker for hypertension and angina that became a blockbuster drug generating over $1 billion annually by the late 1980s[5][7].

Therapeutic areas
GastroenterologyCardiovascularNeurology
Modalities
Small molecules
Industry
Pharma
02

Partnerships

Merger with Merrell Dow Pharmaceuticals (1989)[3][5][7]

Beyond the preview

Go deeper on Marion Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marion Laboratories.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call